CRP and COVID-19: Another study, involving a series of 25 cancer patients with COVID-19 in northern Italy, found that female gender (p = 0.04), multiple primary tumor locations (e.g. genitourinary and hematologic) (p = 0.02), and elevated CRP (p = 0.047) were associated with higher mortality [13].